All episodes

The Other Vaccines

The U.S. and Europe have grown accustomed to hearing about vaccines from Pfizer, Moderna, AstraZeneca, and Johnson & Johnson. How about vaccines developed in Russia, China, and...

Before the novel coronavirus emerged, we had rankings of countries' readiness. Now we have rankings of countries' responses, using all kinds of measures. Co-hosts Jeff Sackmann and...

Masking Up

Are masks truly the lowest-cost major measure we can take to curb the pandemic? Why do some people refuse to wear them? And why do most people in many countries still not have high...

Everything Is A Tradeoff

From lockdowns to research spending to vaccine prioritization, every pandemic decision involves tradeoffs. Co-hosts Jeff Sackmann and Carl Bialik ask for better data to decide on t...

Co-hosts Jeff Sackmann and Carl Bialik ask how well we're doing in administering the Covid-19 vaccine, what we can learn from the country at the top of the scoreboard, and whether ...

Co-hosts Jeff Sackmann and Carl Bialik discuss how the virus variants make the pandemic's exponents all the more dangerous, and consider ways to protect more people from outbreaks ...

Co-hosts Jeff Sackmann and Carl Bialik explore the numbers behind superspreader events. What makes an event a superspreader, how do we know the extent of the spread, and will socie...

Co-hosts Jeff Sackmann and Carl Bialik dig into herd immunity: Is there really such a thing, how do we get there, and how will we know we have? Please let us know what you think of...

Co-hosts Jeff Sackmann and Carl Bialik analyze what's lost and gained when students are kept out of the classroom, and we plead for more data and research on the best way to keep s...

Older Episodes »

Play this podcast on Podbean App